$APRE
Aprea Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Doylestown, PA
APRE chart
What traders are saying about $APRE
Latest postsAprea Therapeutics, Inc. news
- Weekly Recap: APR-1051 responses and stable disease and Q3 loss widens
TradingView ·
- Aprea Therapeutics Stock Rises After Company Reports Second Unconfirmed Case Of Tumor Reduction In Trial
Stocktwits ·
- Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Yahoo Finance ·
- Zentalis Validates a Multibillion-Dollar Cancer Market as Aprea Therapeutics Emerges as a Next-Generation Contender
Barchart.com ·
- Aprea Therapeutics Q3 2026 Earnings Results and Report
MarketBeat ·
- What Could Aprea Therapeutics'(NASDAQ:APRE) WEE1 Inhibitor Mean for Biomarker-Defined Cancers?
Kalkine ·
- Aprea Therapeutics Expands Clinical Trial Network for APR-1051, Ticker APRE
GuruFocus ·
- Form 8K Aprea Therapeutics Inc For: 4 November By Investing.com
Investing.com Nigeria ·
- Aprea Therapeutics 3Q 2026: Revenue $0 Net loss $4.8M, EPS $(0.09) — 10-Q Summary
TradingView ·
- Aprea Therapeutics Q3 net loss widens on higher R&D spending
TradingView ·
- Aprea Therapeutics Announces Third Quarter 2026 Financial Results
Yahoo Finance ·
- Aprea Therapeutics reports Q3 2026 results, adv...
Pluang ·
Aprea Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$12.6M | -$13.0M | -$14.3M | -$112.7M |
| Diluted EPS | $-1.93 | $-2.35 | $-3.95 | $-67.99 |
| Total assets (year end) | $15.9M | $24.0M | $22.7M | $30.2M |
| Cash and equivalents (year end) | $14.6M | $22.8M | $21.6M | $28.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aprea Therapeutics, Inc.
- Ticker
- APRE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Doylestown, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1781983
Frequently asked questions
What exchange is Aprea Therapeutics, Inc. listed on?
Aprea Therapeutics, Inc. trades on the Nasdaq under the ticker symbol APRE.
What industry is Aprea Therapeutics, Inc. in?
Aprea Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aprea Therapeutics, Inc. headquartered?
Aprea Therapeutics, Inc.'s business address on file with the SEC is in Doylestown, PA.
When does Aprea Therapeutics, Inc.'s fiscal year end?
Aprea Therapeutics, Inc.'s fiscal year ends on December 31.